A2A Pharmaceuticals, Inc. has filed 8 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 75000 shares of Biomea Fusion, Inc. ($BMEA) on May 31, 2023.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 75000 | $33.81 | 3,550,000.0000 | 0 | 2.07% | 0.00% |
| June 1, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 50000 | $34.56 | 3,500,000.0000 | 0 | 1.41% | 0.00% |
| May 12, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 25000 | $33.84 | 3,625,000.0000 | 0 | 0.68% | 0.00% |
| May 8, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 100000 | $33.99 | 3,800,000.0000 | 0 | 2.56% | 0.00% |
| May 9, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 150000 | $34.50 | 3,650,000.0000 | 0 | 3.95% | 0.00% |
| April 20, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 200000 | $29.12 | 3,900,000.0000 | 0 | 4.88% | 0.00% |
| March 31, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 200000 | $31.25 | 4,100,000.0000 | 0 | 5.13% | 0.00% |
| March 31, 2023 | Biomea Fusion, Inc. | $BMEA | A2A Pharmaceuticals, Inc. | TenPercentOwner | S | Common Stock | 200000 | $31.25 | 4,100,000.0000 | 0 | 4.65% | 0.00% |